Peptinovo Biopharma is an early-stage start-up biotechnology company, founded by two experienced biotech startup entrepreneurs who have successfully created and exited from previous biotech start-ups. Their combined know-how of both the processes by which natural fats are transported and targeted in the blood and in the discovery and development of chemotherapy drugs has resulted in a novel nanoparticle technology that enables safer transport of chemotherapy drugs to tumors while minimizing the damage to healthy tissues.

The company has strong knowledge of the drug discovery and development process gained during the many years the team worked for small and large pharmaceutical companies.